Sol-Gel Technologies Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SLGL research report →
Range $110 – $110
Price Chart
About the company
Sol-Gel Technologies Ltd. , a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel.
- CEO
- Moshe Arkin
- IPO
- 2018
- Employees
- 28
- HQ
- Ness Ziona, TA, IL
Get TickerSpark's AI analysis on SLGL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $180.63M
- P/E
- -10.55
- Fwd P/E
- 97.70
- PEG
- -0.04
- P/S
- 125.78
- P/B
- 4.22
- EV/EBITDA
- -9.87
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -1220.96%
- Net Margin
- -1115.39%
- ROE
- -38.80%
- ROIC
- -39.77%
Latest fiscal year · YoY change
- Revenue
- $19.39M+68.0%
- Gross Profit
- $19.39M+68.0%
- Op Income
- $-7,538,000
- Net Income
- $-6,127,000+42.1%
- EPS
- $-2.20+42.0%
- OCF Growth
- +102.3%
- FCF Growth
- +102.0%
- 52W High
- $97.97
- 52W Low
- $34.47
- 50D MA
- $65.24
- 200D MA
- $73.70
- Beta
- 1.24
- RSI (14)
- 35
- Avg Volume
- 47.38K
No earnings-call transcripts are available for SLGL yet.
- Free Float
- 26.1%
- Shares Outstanding
- 3.27M
- Float Shares
- 854.35K
of shares held by institutions
24 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Opaleye Management Inc. | 555.00K | ▲ 55.00K |
| Great Point Partners LLC | 239.16K | ▼ 35.20K |
| Trails Edge Capital Partners, LP | 139.44K | 0 |
| Phoenix Financial Ltd. | 113.72K | ▼ 32.42K |
| Affinity Asset Advisors, LLC | 105.00K | ▲ 20.10K |
| Citadel Advisors LLC | 58.34K | ▲ 25.79K |
| Woodline Partners LP | 55.63K | ▲ 55.63K |
| Ark Investment Management LLC | 28.15K | ▲ 28.15K |
| Jane Street Group, LLC | 23.35K | ▲ 14.99K |
| Gilder Gagnon Howe & Co LLC | 23.13K | ▲ 632 |
| Xtx Topco Ltd | 10.34K | ▲ 7.37K |
| Yelin Lapidot Holdings Management Ltd. | 9.08K | ▼ 1.30K |
Held by 3 ETFs
Biggest fund positions in SLGL by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 11, 26 | Opaleye Management Inc. | buy | 1,493 |
| Sep 10, 26 | Opaleye Management Inc. | buy | 1,631 |
| Sep 9, 26 | Opaleye Management Inc. | buy | 3,097 |
| Sep 8, 26 | Opaleye Management Inc. | buy | 471 |
| Sep 8, 26 | Opaleye Management Inc. | buy | 3,390 |
| Sep 4, 26 | Opaleye Management Inc. | buy | 2,100 |
| Sep 4, 26 | Opaleye Management Inc. | buy | 918 |
| Sep 2, 26 | Opaleye Management Inc. | buy | 900 |
| Sep 1, 26 | Opaleye Management Inc. | buy | 783 |
| Aug 31, 26 | Opaleye Management Inc. | buy | 217 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SLGL coverage
Recent articles, reports, and earnings notes.
No research on SLGL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SLGL report →Sol-Gel Technologies (NASDAQ:SLGL) vs. BioAge Labs (NASDAQ:BIOA) Critical Contrast
defenseworld.net · Nov 14
Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Misses Revenue Estimates
zacks.com · Nov 12
Sol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com · Nov 12
Sol-Gel Technologies (NASDAQ:SLGL) & Iterum Therapeutics (NASDAQ:ITRM) Head to Head Review
defenseworld.net · Oct 19
Sol-Gel Technologies (NASDAQ:SLGL) Stock Keeps “Buy” Rating at HC Wainwright
defenseworld.net · Oct 19
Head to Head Analysis: Sol-Gel Technologies (NASDAQ:SLGL) vs. Trulieve Cannabis (NYSE:TRLV)
defenseworld.net · Oct 18
New Strong Buy Stocks for October 16th
zacks.com · Oct 16
Sol-Gel Eyes 2028 Launch as SGT-610 Nears Pivotal Gorlin Syndrome Data
marketbeat.com · Oct 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.